شرکت کوبل دارو
@i_13935
What symbols does the trader recommend buying?
Purchase History
پیام های تریدر
Filter
Signal Type
شرکت کوبل دارو
Cochler Drug Company bought 2.400 million shares on 14/05/18 and currently holds 65.219 % of Dabid's shares in its joint portfolio.
شرکت کوبل دارو
Cochler Daru Company bought 0.300 million shares on 05/05/05 and currently accounts for 65.213 % of Dabid's shares in its joint portfolio.
شرکت کوبل دارو
Cochler Daru Company bought 4.305 million shares on 140/05/04 and currently accounts for 65.213 % of Dabid's shares in its joint portfolio.
شرکت کوبل دارو
Cochler Drug Company has sold 0.010 million shares on 14/02/27 and currently holds 65.202 % of Dabid's shares in its corporate portfolio.
شرکت کوبل دارو
Cochler Drug Company bought 2,000 million shares on 14/02/10 and currently holds 65.202 % of Dabid's shares in its joint portfolio.
شرکت کوبل دارو
شرکت کوبل دارو در تاریخ ۱۴۰۴/۰۲/۰۹، تعداد ۰.۰۴۳ میلیون سهم دعبید را خریداری کرد و اکنون ۶۵.۱۹۷ درصد از سهام دعبید را در پرتفوی سهام خود نگهداری میکند.
شرکت کوبل دارو
شرکت کوبل دارو 0.006 میلیون سهم دعبید را در تاریخ 8 اردیبهشت 1404 خریداری کرد و اکنون 65.197 درصد از سهام دعبید را در پرتفوی سهام خود نگهداری میکند.
شرکت کوبل دارو
Cochler Drug Company bought 0.001 million Shares of Dabid on 14/02/07 and currently holds 65.197 % of Dabid's shares in its joint portfolio.
شرکت کوبل دارو
Cochler Drug Company bought 0.395 million shares of Dabid on 14/02/06 and currently accounts for 65.197 % of Dabid's shares in its joint portfolio.
شرکت کوبل دارو
Cochler Daru Company bought 0.061 million shares of Dabid on 140/02/03 and currently accounts for 65.196 % of Dabid's shares in its portfolio.
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.